How long will a patient remain in the hospital after re-infusion?

What precautions will a patient need to take once they are home?

(Guest Lecture): September 2022 - Using REVLIMID as a Successful Treatment for Myeloma Patients with Kidney Involvement

Can early treatment for MDS prevent progression to AML? If a patient receives early treatment for their MDS, does it still progress to aml in 1/3 of cases? Can you reduce the likelihood of MDS progressing to AML?

Are there different types of MDS?

How quickly can a patient see a response with CAR-T cell therapy?

What is a transfusion and how often would a patient get one?

What is the role of a caregiver?

(Guest Lecture): September 2022 - Know Your Myeloma Therapy: Pomalyst (Pomalidomide)

What are the treatments for low risk and high risk MDS?

What is cytokine release syndrome (CRS)?

When might a transplant be considered in MDS?